Placebo to AIN457 300mg/2mL Solution for injection in pre-filled syringe, SECUKINUMAB clinical trials

A Multicenter, Double-blind, Randomized Withdrawal extension study of subcutaneous secukinumab to demonstrate long-term efficacy, safety and tolerability in subjects with moderate to severe hidradenitis suppurativa

This study is looking at a medicine called secukinumab for people with moderate to severe hidradenitis suppurativa (HS). It aims to see how well the medicine works long-term and if it is safe, especially after people have already seen some improvement.